plerixafor has been researched along with Cicatrization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willyard, C | 1 |
| Cameron, AM; Cui, Z; Gao, B; Lin, Q; Liu, JO; Maeda, H; Montgomery, RA; Sun, Z; Wang, Y; Wesson, RN; Williams, GM | 1 |
2 other study(ies) available for plerixafor and Cicatrization
| Article | Year |
|---|---|
Unlocking the secrets of scar-free skin healing.
Topics: Adipocytes; Adult; Aging; Animals; Antlers; Benzylamines; Bioartificial Organs; Bone Morphogenetic Proteins; Burns; Chemokine CXCL12; Cicatrix; Cyclams; Disease Models, Animal; Female; Fetus; Fibroblasts; Hair Follicle; Heterocyclic Compounds; Humans; Keratinocytes; Male; Mice; Prenatal Injuries; Regeneration; Regenerative Medicine; Reindeer; Skin; Skin Physiological Phenomena; Skin Transplantation; Skin, Artificial; Surgery, Plastic; Wound Healing; Young Adult | 2018 |
Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.
Topics: Animals; Benzylamines; Cell Lineage; Cicatrix; Cyclams; Disease Models, Animal; Drug Synergism; Hair Follicle; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Immunosuppressive Agents; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mice, Knockout; Rats, Inbred Strains; Receptors, CXCR4; Regenerative Medicine; Skin; Tacrolimus; Wound Healing | 2014 |